Maternal antidepressant use and adverse outcomes: A cohort study of 228,876 pregnancies

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 1, 2012, Pages 49.e1-49.e9

  Hayes, Rachel M ^a   Wu, Pingsheng ^a   Shelton, Richard C ^b   Cooper, William O ^a   Dupont, William D ^a   Mitchel, Ed ^a   Hartert, Tina V ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

adverse outcome; maternal antidepressant; preterm birth

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONVULSION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT DISEASE; MAJOR CLINICAL STUDY; MEDICAID; PREGNANCY OUTCOME; PREMATURE LABOR; PRESCRIPTION; PRIMIPARA; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; UNITED STATES;

EID: 84862654905     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.04.028     Document Type: Article

References (27)

1. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;114:703-13.
2. Seguin L, Potvin L, St-Denis M, Loiselle J. Chronic stressors, social support, and depression during pregnancy. Obstet Gynecol 1995;85:583-9.
3. Dayan J, Creveuil C, Herlicoviez M, et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol 2002;155:293-301.
4. Reefhuis J, Rasmussen SA, Friedman JM. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:2188-90.
5. Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007;196:544-5.
6. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194-5.
7. Dietz PM, Williams SB, Callaghan WM, Bachman DJ, Whitlock EP, Hornbrook MC. Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 2007;164:1515-20.
8. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009;163:949-54.
9. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159:2055-61.
10. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5.
11. GlaxoSmithKline. Use of Paroxetine in the first trimester of pregnancy may have a small increased risk of birth defects, compared to other antidepressants. GlaxoSmithKline. 2005. Study EPIP083-Preliminary report. Available at: http://ctr.gsk.co.uk/Summary/paroxetine/studylist.asp. Accessed May 14, 2012.
12. Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998;279:609-10.
13. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482-7.
14. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-96.
15. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007;356:2684-92.
16. Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-83.
17. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health 1994;84:1414-20.
18. Harrell FE Jr. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
19. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54:167-79.
20. Agresti A. Categorical data analysis, 2nd ed. Hoboken, NJ: John Wiley & Sons; 2002.
21. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 2008;192:338-43.
22. Ramos E, St-Andre M, Berar A. Association between antidepressant use during pregnancy and infants born small for gestational age. Can J Psychiatry 2010;55:643-52.
23. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M. Neonatal outcome following maternal antenatal depression and anxiety: a population-based study. Am J Epidemiol 2004;159:872-81.
24. Orr ST, James SA, Blackmore PC. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol 2002;156:797-802.
25. Steer RA, Scholl TO, Hediger ML, Fischer RL, Bixo M. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 1992;45:1093-9.
26. Loftin R, Chen A, Evans A, Defranco E. Racial differences in gestational age-specific neonatal morbidity: further evidence for different gestational lengths. Am J Obstet Gynecol 2012;206:259.e1-6.
27. Hrastovec A, Hostnik T, Neubauer D. Benign convulsions in newborns and infants: occurrence, clinical course and prognosis. Eur J Paediatr Neurol 2012;16:64-73.